ID: ALA4859261

Max Phase: Preclinical

Molecular Formula: C22H31N5O

Molecular Weight: 381.52

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CCn1c2ccccc2n2c(C(=O)C3CCNCC3)c(C)nc12

Standard InChI:  InChI=1S/C22H31N5O/c1-4-25(5-2)14-15-26-18-8-6-7-9-19(18)27-20(16(3)24-22(26)27)21(28)17-10-12-23-13-11-17/h6-9,17,23H,4-5,10-15H2,1-3H3

Standard InChI Key:  KTQHJWBEOPAYDC-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily M member 2 348 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 381.52Molecular Weight (Monoisotopic): 381.2529AlogP: 3.12#Rotatable Bonds: 7
Polar Surface Area: 54.57Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.12CX LogP: 1.73CX LogD: -2.64
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -1.24

References

1. Zhao S, Zhang H, Jin H, Cai X, Zhang R, Jin Z, Yang W, Yu P, Zhang L, Liu Z..  (2021)  Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitors.,  225  [PMID:34416664] [10.1016/j.ejmech.2021.113750]

Source